Why the Cancer Caregiver Journey Cannot Be Overlooked When Discussing Patient Care

Video

Heather Badt, CSC’s Executive Director of the Research & Training Institute, recently shared her personal perspective as a former patient and caregiver with CURE® and expanded on how those who care for loved ones with cancer often face their own unique challenges and require specialized resources themselves

Those who care for loved ones with cancer often face their own unique challenges and require specialized resources themselves, according to Cancer Support Community (CSC)’s 2020 Cancer Experience Registry Report. Because caregivers are a crucial part of the cancer care team, caring for them and addressing their needs is even more important.

Heather Badt, CSC’s Executive Director of the Research & Training Institute, recently shared her personal perspective as a former patient and caregiver with CURE® and expanded on how the report’s findings highlight the need for resources specially designed for caregivers.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Transcription:

I think what I'd love to do is also share on a personal note that I'm a former patient and caregiver, so my comments are coming from both a personal and a professional perspective.

And one of the reasons why (caring for the caregiver) is so critical is confronting cancer itself. We often overlook that the people living with cancer are the patient and the caregiver. It's a mindset that we have to collectively really shift.

It's well known that quality caregiving can lead to better patient outcomes, and that caregivers are often a critical player in the decision-making process. At CSC, we've learned that the caregivers’ journey can be as hard as the patients, and in our 2020 Registry Report, some of the highlights that we share are that caregivers are spending over 100 hours of care a week, and that many are showing a decline in their own personal health.

Half the caregivers in the report were concerned about balancing caregiving with other demands in their life. Three out of four wanted help understanding the patient's medical condition and treatment, but more than half also felt they were not prepared to care for the patient's emotional needs. We have to make sure that caregivers are reaching out for help and getting access to all these different types of resources.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE
Dr. Barzi in an interview with CURE
Sue Friedman in an interview with CURE
Dr. Giles in an interview with CURE
Related Content